The COVID-19 pandemic brought messenger RNA (mRNA) vaccines to the forefront of global health care. After their clinical ...
A public health expert breaks down the most important public health issues on the agenda for the CDC's vaccine advisory ...
Lo detailed that the Dynavax partnership, announced in November 2025, included a $25 million upfront payment and $5 million equity investment. The agreement holds "a total potential value of up to ...
CHATHAM, N.J., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a fully-integrated biopharmaceutical company with marketed products and a ...
Public health experts criticize Retsef Levi’s studies ahead of a key vaccine advisory meeting ...
Moderna Inc.’s settlement to end a lawsuit over technology used in its Covid-19 vaccine caps its potential exposure at $2.25 ...
An experimental treatment protects mice from COVID-19, flu, bacteria, and more.
Classical vaccines often rely on traditional technologies, such as live attenuated or inactivated pathogens, which carry inherent risks including reduced immunogenicity under certain conditions and ...
As measles cases in South Carolina continue to rise, vaccine supporters and opponents clashed Wednesday over two dueling ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results